drugset
Drugs / Cord Tissue Mesenchymal Stromal Cells
last change Feb 2024 re-read 3 minutes ago

Cord Tissue Mesenchymal Stromal Cells

also known as hCT-MSC · Human Umbilical Cord Tissue Derived Mesenchymal Stromal Cells

Cell therapy

Developed for
autism
Investigated by
Cryo-Cell International · Joanne Kurtzberg, MD · The Marcus Foundation

Trials 1

today NCT04089579 · Ph 2
202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT04089579 Oct 2020 → May 2023 autism Joanne Kurtzberg, MD Completed Missed primary

Evidence & citations 5 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Cord Tissue Mesenchymal Stromal Cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT04089579 ↗
Known as hCT-MSC “Human Umbilical Cord Tissue Derived Mesenchymal Stromal Cells (hCT-MSC), isolated and expanded from umbilical cord tissue from allogeneic unrelated donors.” NCT04089579 ↗
Known as Human Umbilical Cord Tissue Derived Mesenchymal Stromal Cells “Human Umbilical Cord Tissue Derived Mesenchymal Stromal Cells (hCT-MSC), isolated and expanded from umbilical cord tissue from allogeneic unrelated donors.” NCT04089579 ↗
Modality Cell therapy “Mesenchymal Stromal Cells” NCT04089579 ↗
Route Intravenous “administered intravenously” NCT04089579 ↗